Advertisement
Advertisement

COR

COR logo

Cencora, Inc.

311.43
USD
Sponsored
-0.56
-0.18%
Apr 29, 15:59 UTC -4
Closed
exchange

After-Market

308.02

-3.41
-1.10%

COR Earnings Reports

Positive Surprise Ratio

COR beat 37 of 40 last estimates.

93%

Next Report

Next Week
Date of Next Report
May 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
$81.86B
/
$4.86
Implied change from Q1 26 (Revenue/ EPS)
-4.74%
/
+19.12%
Implied change from Q2 25 (Revenue/ EPS)
+8.49%
/
+9.95%

Cencora, Inc. earnings per share and revenue

On Feb 04, 2026, COR reported earnings of 4.08 USD per share (EPS) for Q1 26, beating the estimate of 4.07 USD, resulting in a 0.03% surprise. Revenue reached 85.93 billion, compared to an expected 86.89 billion, with a -1.10% difference. The market reacted with a -8.79% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 17 analysts forecast an EPS of 4.86 USD, with revenue projected to reach 81.86 billion USD, implying an increase of 19.12% EPS, and decrease of -4.74% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Danaher Corporation
Report Date
Apr 21, 2026 For Q1 26
Estimate
$1.95
Actual
$2.06
Surprise
+5.31%
logo
HCA Healthcare, Inc.
Report Date
Apr 24, 2026 For Q1 26
Estimate
$7.21
Actual
$7.15
Surprise
-0.85%
logo
Elevance Health, Inc.
Report Date
Apr 22, 2026 For Q1 26
Estimate
$10.93
Actual
$12.58
Surprise
+15.10%
logo
Medpace Holdings, Inc. Common Stock
Report Date
Apr 22, 2026 For Q1 26
Estimate
$3.95
Actual
$4.28
Surprise
+8.14%
logo
Bausch + Lomb Corporation
Report Date
Apr 29, 2026 For Q1 26
Estimate
$0.05
Actual
$0.08
Surprise
+36.52%
logo
Avantor, Inc.
Report Date
Apr 29, 2026 For Q1 26
Estimate
$0.16
Actual
$0.17
Surprise
+6.18%
logo
Teladoc Health, Inc.
Report Date
Apr 29, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.36
Surprise
-12.64%
logo
CareDx, Inc.
Report Date
Apr 28, 2026 For Q1 26
Estimate
$0.13
Actual
$0.34
Surprise
+149.63%
FAQ
For Q1 2026, Cencora, Inc. reported EPS of $4.08, missing estimates by 0.03%, and revenue of $85.93B, -1.1% below expectations.
The stock price moved down -8.79%, changed from $361.75 before the earnings release to $329.97 the day after.
The next earning report is scheduled for May 06, 2026.
Based on 17 analysts, Cencora, Inc. is expected to report EPS of $4.86 and revenue of $81.86B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement